Hera BioLabs Email Format

Biotechnology ResearchKentucky, United States2-10 Employees

Hera BioLabs is a small biotechnology research company based in Lexington, Kentucky, focused on developing piggyBac-based tools to generate in vivo reporter cell lines for cancer research. The firm has pursued the PiggyBac transposon platform to enable rapid creation of reporter cells and has worked on related expression systems, including Firefly Luciferase, and on a program involving the SRG rat OncoRat. In 2025, Hera BioLabs was fully integrated into Demeetra AgBio, with the acquisition closing on June 1 and consolidating Super piggyBac licensing under a single organization. As a result, Demeetra now serves as the definitive commercial source for Super piggyBac licensing across a broad range of research and commercial applications. Reports indicate that Hera BioLabs’ assets and piggyBac rights were transferred to Demeetra AgBio in 2025, with licenses granted directly by Demeetra thereafter.

Sign up for free to view info

Company overview Employee directory